Autolus Therapeutics (AUTL) Amortizatization of Intangibles (2024 - 2025)
Autolus Therapeutics posted quarterly Amortizatization of Intangibles of -$1.3 million for Q4 2025, down 734.0% year-on-year from $200000.0 in Q4 2024, and down 353.6% on a QoQ basis from $500000.0 in Q3 2025.
Autolus Therapeutics (AUTL) has 2 years of Amortizatization of Intangibles data on file, last reported at -$1.3 million in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles fell 734.0% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at -$183000.0 (down 191.5% YoY), and the FY2025 full-year result was $1.5 million, up 650.0% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at -$1.3 million, down from $500000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $500000.0 in Q3 2025 and bottomed at -$1.3 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.27 Mn |
| Dec 31, 2025 | -1.27 Mn |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 285,000.00 |
| Mar 31, 2025 | 285,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |